Real time, small animal whole body imaging platform for fast screening of all PET radiopharmaceuticals
Features
- Small animal, PET isotope, 2D or 3D live imaging platform
- Real time, whole body imaging post injection
- Fast screening of radiolabeled compounds
- Suitable for organ ex vivo imaging
- Compatible with 3rd party anesthesia and vital signs monitoring systems
Performance
- State-of-the-art detector characteristics
- <1.2mm spatial resolution at Center of Field of View
- Sensitivity of 2.9% at Center of Field of View
- Time-of-Flight performance for improved Signal-to-Noise ratio
- Down to 10 seconds frames for whole body scans
- Energy resolution of 12.4% at 511 keV
- Weight less than 40kg
- Dimensions: 43cm (L) x 46cm (W) x 43cm (H)
Definition of a user friendly platform
- Straightforward workflow with easy imaging protocol set-up
- Easy to operate by non highly-experienced professionals
- Footprint allowing for easy system installation and transfer
- Ideal for imaging inside a clean room, or next to a cyclotron
- Visual | eyesTM software hub for post processing of imaging data
Option for 3D PET imaging with the press of a button
- Upgrade your study portfolio with more applications like neuroimaging, orthotopic oncology and more
- Enhanced quantification
- More dosimetry-friendly
- Distinguish and better understand complex structures
Applications
[18]F imaging using the β-eye™
Free F-18 accumulating in bones. Image acquired at BIOEMTECH preclinical laboratories. Image info: 1h post injection acquisition, 10 min static scan. Total injected dose: 70 uCi / 2.59 MBq
Applications
[18]F-FDG imaging with wild-type zebra fish, using β-eye™
Here, we present an example of an adult zebrafish injected intravenously with 18F-FDG on a dose of 0.16 MBq / 4.25 uCi and imaged right after injection. The study duration was equal to 6 minutes. Several organs were easily distinguishable. This work was conducted in collaboration with Dr. Vasiliki Tsata , from the Biomedical Research Foundation of the Academy of Athens.
Applications
Oncology, 3D
Cardiac PET imaging using [18]F-FDG
2D imaging allows us to detect critical features, such as a tumor in necrosis. However, the incorporation of 3D capabilities enables a further advancement in the resolution of structures and functions within vital organs, such as the heart, thereby facilitating a more comprehensive understanding. Image info: 1 hr post injection acquisition - 60 min dynamic scan - total injected dose 5,45MBq
Publications
- A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cellsRead More
- A technique to quantify very low activities in regions of interest with a collimatorless detectorRead More
- Preparation, Radiolabeling with 68Ga/177Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer TargetingRead More
- Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based TheranosticsRead More
- Practical considerations for navigating the regulatory landscape of non‑clinical studies for clinical translation of radiopharmaceuticalsRead More
- β-eye™: A benchtop system for in vivo molecular screening of labeled compoundsRead More
- Evaluation of Hamamatsu H13974 Large Sensitive Area Flat Panel PMT Array for Use in Small Animal Imaging and ScintimammographyRead More
- Characterization of “γ-eye™”: a Low-Cost Benchtop Mouse-Sized Gamma Camera for Dynamic and Static Imaging StudiesRead More
- 212Pb-DOTAM-peptide targeting LDLR-receptors in glioblastoma and pancreatic ductal adenocarcinomaRead More
Looking for more info on the β-eye™ and its applications?
Download the β-eye™ Brochure